Regulation of breast cancer-associated aromatase promoters

Bulun, 2005, Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment, Pharmacol. Rev., 57, 359, 10.1124/pr.57.3.6 Grodin, 1973, Source of estrogen production in postmenopausal women, J. Clin. Endocrinol. Metab., 36, 207, 10.1210/jcem-36-2-207 Bulun, 1994, Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age, J. Clin. Endocrinol. Metab., 78, 428, 10.1210/jc.78.2.428 Miller, 1997, Regulation of aromatase activity within the breast, J. Steroid Biochem. Mol. Biol., 61, 193, 10.1016/S0960-0760(97)80012-X van Landeghem, 1985, Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue, Cancer Res., 45, 2900 Bulun, 1993, A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription, J. Clin. Endocrinol. Metab., 77, 1622, 10.1210/jc.77.6.1622 Agarwal, 1996, Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients, J. Clin. Endocrinol. Metab., 81, 3843, 10.1210/jc.81.11.3843 Baum, 2002, Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial, Lancet, 359, 2131, 10.1016/S0140-6736(02)09088-8 Simpson, 2002, Aromatase--a brief overview, Annu. Rev. Physiol., 64, 93, 10.1146/annurev.physiol.64.081601.142703 Means, 1989, Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesi, J. Biol. Chem., 264, 19385, 10.1016/S0021-9258(19)47313-4 Price, 1992, Determination of aromatase cytochrome P450 messenger ribonucleic acid in human breast tissue by competitive polymerase chain reaction amplification, J. Clin. Endocrinol. Metab., 74, 1247, 10.1210/jc.74.6.1247 Ackerman, 1981, Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture, J. Clin. Endocrinol. Metab., 53, 412, 10.1210/jcem-53-2-412 Meng, 2001, Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction, Cancer Res., 61, 2250 Harada, 1997, Aberrant expression of aromatase in breast cancer tissues, J. Steroid Biochem. Mol. Biol., 61, 175, 10.1016/S0960-0760(97)80010-6 Diaz-Cruz, 2005, Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells, J. Clin. Endocrinol. Metab., 90, 2563, 10.1210/jc.2004-2029 Zhou, 2001, Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta, Cancer Res., 61, 2328 Zhao, 1996, Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene, Endocrinology, 137, 5739, 10.1210/en.137.12.5739 Sebastian, 2002, Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue, Mol. Endocrinol., 16, 2243, 10.1210/me.2002-0123 Zhao, 1995, Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes, Mol. Endocrinol., 9, 340, 10.1210/me.9.3.340 Zhao, 1995, Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter, J. Biol. Chem., 270, 16449, 10.1074/jbc.270.27.16449 Zhao, 1996, Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4, Mol. Endocrinol., 10, 1350, 10.1210/me.10.11.1350 Deb, 2004, Estrogen regulates expression of tumor necrosis factor receptors in breast adipose fibroblasts, J. Clin. Endocrinol. Metab., 89, 4018, 10.1210/jc.2004-0127 Rubin, 2000, Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy, Cancer Res., 60, 1604 Zhou, 1997, Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells, J. Steroid Biochem. Mol. Biol., 61, 273, 10.1016/S0960-0760(97)80023-4 Zhou, 1999, Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene, Arch. Biochem. Biophys., 371, 179, 10.1006/abbi.1999.1454 Chen, 2001, Modulation of aromatase expression in human breast tissue, J. Steroid Biochem. Mol. Biol., 79, 35, 10.1016/S0960-0760(01)00132-7 Clyne, 2002, Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes, J. Biol. Chem., 277, 20591, 10.1074/jbc.M201117200 Deb, 2006, A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts, J. Biol. Chem., 281, 2585, 10.1074/jbc.M508498200 Breyer, 2001, Prostanoid receptors: subtypes and signaling, Annu. Rev. Pharmacol. Toxicol., 41, 661, 10.1146/annurev.pharmtox.41.1.661 Chen, 2007, Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts, Cancer Res., 67, 8914, 10.1158/0008-5472.CAN-06-4751 Evans, 1987, Regulation of estrogen biosynthesis in human adipose stromal cells. Effects of dibutyryl cyclic AMP, epidermal growth factor, and phorbol esters on the synthesis of aromatase cytochrome P-450, J. Biol. Chem., 262, 6914, 10.1016/S0021-9258(18)48331-7 Mendelson, 1986, Growth factors suppress and phorbol esters potentiate the action of dibutyryl adenosine 3′,5′-monophosphate to stimulate aromatase activity of human adipose stromal cells, Endocrinology, 118, 968, 10.1210/endo-118-3-968 Sands, 2008, Regulating gene transcription in response to cyclic AMP elevation, Cell. Signal., 460, 10.1016/j.cellsig.2007.10.005 Sofi, 2003, Role of CRE-binding protein (CREB) in aromatase expression in breast adipose, Breast Cancer Res. Treat., 79, 399, 10.1023/A:1024038632570 Derijard, 1994, JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain, Cell, 76, 1025, 10.1016/0092-8674(94)90380-8 Raingeaud, 1996, MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway, Mol. Cell. Biol., 16, 1247, 10.1128/MCB.16.3.1247 Gupta, 1995, Transcription factor ATF2 regulation by the JNK signal transduction pathway, Science, 267, 389, 10.1126/science.7824938 Lynch, 1993, Steroidogenic factor 1, an orphan nuclear receptor, regulates the expression of the rat aromatase gene in gonadal tissues, Mol. Endocrinol., 7, 776, 10.1210/me.7.6.776 Zhou, 2005, Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer, Cancer Res., 65, 657, 10.1158/0008-5472.657.65.2 Safi, 2005, Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy, Cancer Res., 65, 11762, 10.1158/0008-5472.CAN-05-2792 Miki, 2007, Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells, Cancer Res., 67, 3945, 10.1158/0008-5472.CAN-06-3105 Yang, 2002, Regulation of aromatase promoter activity in human breast tissue by nuclear receptors, Oncogene, 21, 2854, 10.1038/sj.onc.1205386 Yang, 1998, Modulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptor, Cancer Res., 58, 5695 Okubo, 2001, Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH), Cancer Res., 61, 1338 Kovacic, 2004, Inhibition of aromatase transcription via promoter II by short heterodimer partner in human preadipocytes, Mol. Endocrinol., 18, 252, 10.1210/me.2003-0211 Lee, 2002, Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner, J. Biol. Chem., 277, 2463, 10.1074/jbc.M105161200 Rubin, 2002, Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose, Endocrinology, 143, 2863, 10.1210/en.143.8.2863 Lu, 2006, BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells, J. Clin. Endocrinol. Metab., 91, 4514, 10.1210/jc.2006-1364 Ghosh, 2007, Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells, Am. J. Physiol. Endocrinol. Metab., 292, E246, 10.1152/ajpendo.00242.2006 Jaenisch, 2003, Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals, Nat. Genet., 33, 245, 10.1038/ng1089 Demura, 2008, CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity, Mol. Cell. Endocrinol., 283, 127, 10.1016/j.mce.2007.12.003 Lebovitz, 2002, Differentiating members of the thiazolidinedione class: a focus on safety, Diabetes Metab. Res. Rev., 18, S23, 10.1002/dmrr.252 Zhang, 2006, Treatment of cutaneous T-cell lymphoma with retinoids, Dermatol. Ther., 19, 264, 10.1111/j.1529-8019.2006.00083.x Sharma, 2005, Novel drugs targeting retinoic acid receptors, JK Science, 7, 1 Nakagawa, 2007, Clinical results of continuous intrathecal or intracavitary administration of sodium butyrate for patients with recurrent and progressive malignant glioma: Experience with 23 cases, J. Clin. Oncol. (Meeting Abstracts), 25, 2040, 10.1200/jco.2007.25.18_suppl.2040 Weidle, 2000, Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment, Anticancer Res., 20, 1471 Gore, 2000, Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors, Expert Opin. Investig. Drugs, 9, 2923, 10.1517/13543784.9.12.2923 Braddock, 2006, 10th anniversary Inflammation and Immune Diseases Drug Discovery and Development Summit. 20-21 March 2006, New Brunswick, USA, Expert Opin. Investig. Drugs, 15, 721, 10.1517/13543784.15.6.721 Sweeney, 2006, Mitogen activated protein kinase inhibitors: where are we now and where are we going?, Ann. Rheum. Dis., 65, 83 Karin, 2005, From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance, IUBMB Life, 57, 283, 10.1080/15216540500097111 Schiffelers, 2004, Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle, Nucleic Acids Res., 32, e149, 10.1093/nar/gnh140 Morales, 2005, Choosing between an aromatase inhibitor and tamoxifen in the adjuvant setting, Curr. Opin. Oncol., 17, 559, 10.1097/01.cco.0000180434.31991.bf